NEW YORK (GenomeWeb News) — UK-based synthetic polymer company Chromatide said today that it has received an undisclosed second round of financing from Enterprise Ventures and Alliance Fund Managers, both of which invested in it in 2007.
Chromatide, which plans to use the money to continue expanding its IP portfolio, said that since the first investment it has "successfully delivered on a range of technical and commercial" milestones.
CEO Clare Hildred said in a statement that the company is using its expertise to develop a range of new technologies for biomolecule purification, polymer synthesis, chemical processes, and instrument design.
AFM offers loans and equity packages ranging from £3,000 ($4,300) to £4 million to businesses located in Merseyside, UK.
EV is an independent fund manager that provides private equity and venture capital to regional groups located throughout Northern England and the Midlands region.